Home Infusion Therapy Market Report

Home Infusion Therapy Market Analysis By Product (Infusion Pumps, IV Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infectives, Endocrinology, Hydration Therapy, Parenteral Nutrition), And Segment Forecasts, 2018 - 2024

  • Published Date: Dec, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-389-8
  • Format: Electronic (PDF)
  • Historical Data: 2013 - 2015
  • Number of Pages: 100

Industry Insights

The global home infusion therapy market size was valued at USD 13.0 billion in 2015. Key drivers contributing to market expansion include the rising geriatric population, increase in disease burden, and presence of high unmet medical needs in the low income regions.

U.S. home infusion therapy market, by product, 2013 - 2024, (USD Billion)

U.S. home infusion therapy Market

The introduction of smart pumps has enabled access to homecare infusion therapies. Such devices are enhancing the overall ease of use for patients. Moreover, rising demand for reduction in inpatient stay due to the associated hospital expenses has led to the development of infusion therapy in alternative healthcare settings such as homecare, thus resulting in overall market growth.

In addition, the growing requirement to contain healthcare costs has led to a higher preference for homecare therapies amongst patients, especially the elderly, requiring long-term care. Infusion pumps offer numerous benefits in comparison to manual delivery of fluids owing to their ability to administer the desired volume of fluids at preprogrammed and automated intervals. Furthermore, the wide scale availability of smart infusion pumps provided by the key players is expected to boost the market demand.

With the growing geriatric population, there will be an increase in the incidence of various medical conditions necessitating prolonged care. The high preference of this patient subset to convalesce at home is expected to significantly propel the market growth.

Product Insights

Infusion pumps accounted for the largest market share of over 49.0% in 2015. This is primarily due to the fact that these devices were used in inpatient facilities worldwide and are now being incorporated extensively in outpatient settings as well. These pumps ensure greater level of precision and accuracy in delivering drugs leading to reduced errors in drug administration. Hence, this has led to increased adoption of these devices subsequently leading to overall growth of this vertical.

Needleless connectors are expected to be the fastest growing segment over the forecast period owing to technological advancements in these connectors, resulting in reduced risk of injuries and disease transmission.

Previously, approximately 385,000 injuries per year were reported due to the usage of needle connectors posing a high risk of pathogen transmission. Hence, in the near future these needleless devices are projected to contribute, to a large extent, toward revenue generation.

Application Insights

Anti-infectives, comprising antibiotics, antivirals, and antifungals, to treat infections that require long-term intravenous therapy are the most common form of therapies provided to patients in home settings. Hence, it contributed toward the largest revenue generation in 2015.

Global home infusion therapy market, by application, 2015

Global home infusion therapy Market

The chemotherapy pumps used at home are continuous pressure pumps that do not require a battery and are compactly sized. As a result of this, the chemotherapy segment is anticipated to attain a lucrative CAGR of over 9.0% over the forecast period. Endocrinology segment is also estimated to witness profitable growth owing to the convenience of using insulin pumps.

Regional Insights

North America dominated the market in 2015 with revenue of around USD 5.0 billion due to the presence of a well-established government reimbursement plans in this region. Several government health plans advanced by the Centers for Medicare and Medicaid Services and Federal Employees Health Benefits Program provide reimbursement for infusion therapy.

Asia Pacific is expected to gain the highest CAGR over the forecast period owing to the rising patient awareness levels in this region. This is primarily due to the benefits of homecare therapies as compared to that of in-hospital infusion procedures.

Competitive Insights

Some of the key participants comprise Baxter, Caesarea Medical Electronics, B. Braun Melsungen AG, CareFusion Corporation, ICU Medical, Inc., Fresenius Kabi AG, JMS Co. Ltd., Terumo Corporation, and Smiths Medical.

The companies are focusing on mergers and acquisitions to widen their market presence. For instance, in December 2013, CareFusion bought 40% stake in Caesarea to expand its infusion product portfolio. Furthermore, geographical expansions and product launches are some of the major strategies undertaken by the companies. For instance, in April 2016, Smiths Medical launched their wireless infusion system, CADD Solis for efficient pain management, in New Zealand, Ireland, Australia, and the UK.

Report Scope



Base year for estimation


Actual estimates/Historical data

2013 - 2015

Forecast period

2016 - 2024

Market representation

Revenue in USD Million & CAGR from 2016 to 2024

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa

Report coverage              

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research has segmented the home infusion therapy market on the basis of product, application and region:

  • Product Outlook (Revenue, USD Million, 2013 - 2024)

    • Infusion pumps

    • Ambulatory infusion pumps

      • Insulin pumps

      • Syringe pumps

      • Elastomeric pumps

      • Patient Controlled Analgesics (PCA)

    • Intravenous Sets

    • IV cannulas

    • Needleless connectors

  • Application Outlook (Revenue, USD Million, 2013 - 2024)

    • Anti-Infective

    • Endocrinology

      • Diabetes

      • Others

    • HydrationTherapy

      • Athletes

      • Others

    • Chemotherapy

    • Enteral Nutrition

    • Parenteral Nutrition

    • Speciality Pharmaceuticals

    • Others

  • Regional Outlook (Revenue, USD Million, 2013 - 2024)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Mexico

      • Brazil

    • Middle East and Africa (MEA)

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,250
Multi User (2-5) - $5,250
Enterprise Access - $7,250

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified